An interventional study of Weight loss in Overweight, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 19 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-09-14.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment
The primary aim of this research project is to determine whether the incorporation of food products containing medium chain triglyceride (MCT) oil in a weight-loss program results in a different degree of weight-loss and total and regional fat mass loss than the incorporation of extra light olive oil. The secondary goals are to test whether there are differences in in metabolic risk profile changes between the 2 diets. We hypothesize that men and women who consumed MCT oil as part of their weight loss program will lose more weight and body fat than those who consume olive oil in their weight loss diet.
3,670 studies on the registry are indexed under Overweight; 850 are open to participants now.
This study's enrollment of 53 is below the median of 73 across 3,175 interventional studies indexed under Overweight.
Browse Overweight studies →University of Alabama at Birmingham is the lead sponsor of 1,394 studies on the registry; 282 are open to participants now.
Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
MCT oil consumption
Dietary Supplement: Weight loss
Olive oil consumption
Dietary Supplement: Weight loss
Weight loss study including consumption of either 22-25 g of medium chain triglyceride oil or olive oil
Also known as: MCT oil, Neobee 1053, Stepan Company
Change in body weight and fat mass, change in plasma lipid concentrations, fasting glucose and fasting insulin
Time frame: 16 weeks
Change in blood pressure, change in fat-free mass
Time frame: 16 weeks
This study is completed, as verified in Sep 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham